CQ-16

Overview

CQ-16 is an orally active small molecule drug conjugate (SMDC) targeting prostate-specific membrane antigen ( PSMA ). CQ-16 exhibits highly selective antiproliferative activity between PSMA -positive and PSMA -negative prostate cells. In addition, CQ-16 also has PARP inhibitory activity ( IC 50 =1 nM). (Pink: PSMA Ligand ( HY-139840 ); Black: Linker ( HY-W037980 ); Blue: PARP Inhibitor ( HY-10162 ))

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > PARP | Products > Signaling Pathways > PSMA

Product Information

• Catalog No.: HY-169336
• CAS No.: 3024354-59-1
• Molecular Formula: C40H47FN8O12
• Molecular Weight: 850.85
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source